Ver mas grande
RIMKLB antibody
FT-FNab07303
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB |
| Target | RIMKLB |
| Research Area | Metabolism |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | ribosomal modification protein rimK-like family member B |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Beta-citrylglutamate synthase B|N-acetyl-aspartylglutamate synthetase B (NAAG synthetase B, NAAGS)|Ribosomal protein S6 modification-like protein B|RIMKLB|FAM80B|KIAA1238 |
| Host | Rabbit |
| UniProt ID | Q9ULI2 |
| Gene ID | 57494 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse |
| Observed MW | 42-48 kDa |
| Background | Catalyzes the synthesis of beta-citryl-L-glutamate and N-acetyl-L-aspartyl-L-glutamate. Beta-citryl-L-glutamate is synthesized more efficiently than N-acetyl-L-aspartyl-L-glutamate. |
Más información
RIMKLB antibody